Titre : Systèmes hospitaliers de distribution

Systèmes hospitaliers de distribution : Questions médicales fréquentes

Termes MeSH sélectionnés :

Language Development Disorders
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Systèmes hospitaliers de distribution : Questions médicales les plus fréquentes", "headline": "Systèmes hospitaliers de distribution : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Systèmes hospitaliers de distribution : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-19", "dateModified": "2025-04-13", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Systèmes hospitaliers de distribution" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Administration hospitalière", "url": "https://questionsmedicales.fr/mesh/D006739", "about": { "@type": "MedicalCondition", "name": "Administration hospitalière", "code": { "@type": "MedicalCode", "code": "D006739", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N04.452.442.452" } } }, "about": { "@type": "MedicalCondition", "name": "Systèmes hospitaliers de distribution", "alternateName": "Hospital Distribution Systems", "code": { "@type": "MedicalCode", "code": "D006750", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Nathaniel P Sheehan", "url": "https://questionsmedicales.fr/author/Nathaniel%20P%20Sheehan", "affiliation": { "@type": "Organization", "name": "Department of Geography and Environmental Engineering, United States Military Academy, West Point, New York, USA." } }, { "@type": "Person", "name": "Erick Martinez", "url": "https://questionsmedicales.fr/author/Erick%20Martinez", "affiliation": { "@type": "Organization", "name": "Department of Chemistry and Life Science, United States Military Academy, West Point, New York, USA." } }, { "@type": "Person", "name": "Kyle Murray", "url": "https://questionsmedicales.fr/author/Kyle%20Murray", "affiliation": { "@type": "Organization", "name": "Department of Geography and Environmental Engineering, United States Military Academy, West Point, New York, USA." } }, { "@type": "Person", "name": "Peter Bier", "url": "https://questionsmedicales.fr/author/Peter%20Bier", "affiliation": { "@type": "Organization", "name": "U.S. Army Combined Arms Center, Fort Leavenworth, Kansas, USA." } }, { "@type": "Person", "name": "Jessica M Allan", "url": "https://questionsmedicales.fr/author/Jessica%20M%20Allan", "affiliation": { "@type": "Organization", "name": "Pediatric Hospital Medicine, Department of Pediatrics, Palo Alto Medical Foundation, Palo Alto, California." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Psychometric Correlation of Personality Disorders Along With Defense Mechanisms in Mexican Individuals With Depressive and Anxious Disorders: A Cross-Sectional Study.", "datePublished": "2023-01-15", "url": "https://questionsmedicales.fr/article/36660239", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.7759/cureus.33805" } }, { "@type": "ScholarlyArticle", "name": "Plasma neuropeptide levels in patients with schizophrenia, bipolar disorder, or major depressive disorder and healthy controls: A multiplex immunoassay study.", "datePublished": "2022-11-22", "url": "https://questionsmedicales.fr/article/36414415", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/npr2.12304" } }, { "@type": "ScholarlyArticle", "name": "Can developmental trauma disorder be distinguished from posttraumatic stress disorder? A symptom-level person-centred empirical approach.", "datePublished": "2022-11-02", "url": "https://questionsmedicales.fr/article/36340008", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/20008066.2022.2133488" } }, { "@type": "ScholarlyArticle", "name": "Risk-to-befit ratios of consecutive antidepressants for heavy menstrual bleeding in young women with bipolar disorder or major depressive disorder.", "datePublished": "2022-10-28", "url": "https://questionsmedicales.fr/article/36386987", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fpsyt.2022.1012644" } }, { "@type": "ScholarlyArticle", "name": "Substance Use, Substance Use Disorders, and Co-Occurring Psychiatric Disorders in Recently Incarcerated Men: A Comparison with the General Population.", "datePublished": "2022-08-25", "url": "https://questionsmedicales.fr/article/36007504", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1159/000526079" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Administration des services de santé", "item": "https://questionsmedicales.fr/mesh/D006298" }, { "@type": "ListItem", "position": 3, "name": "Organisation et administration", "item": "https://questionsmedicales.fr/mesh/D009934" }, { "@type": "ListItem", "position": 4, "name": "Administration d'établissement de santé", "item": "https://questionsmedicales.fr/mesh/D058016" }, { "@type": "ListItem", "position": 5, "name": "Administration hospitalière", "item": "https://questionsmedicales.fr/mesh/D006739" }, { "@type": "ListItem", "position": 6, "name": "Systèmes hospitaliers de distribution", "item": "https://questionsmedicales.fr/mesh/D006750" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Systèmes hospitaliers de distribution - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Systèmes hospitaliers de distribution", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-16", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Systèmes hospitaliers de distribution", "description": "Comment évaluer l'efficacité d'un système de distribution ?\nQuels indicateurs surveiller dans un système de distribution ?\nComment identifier les problèmes dans la distribution ?\nQuels outils pour le diagnostic des systèmes de distribution ?\nComment mesurer la satisfaction des utilisateurs ?", "url": "https://questionsmedicales.fr/mesh/D006750?mesh_terms=Language+Development+Disorders&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Systèmes hospitaliers de distribution", "description": "Quels symptômes d'un système de distribution défaillant ?\nComment reconnaître une surcharge du système ?\nQuels impacts sur les patients d'un mauvais système ?\nQuels signes d'inefficacité dans la distribution ?\nComment les erreurs de distribution se manifestent-elles ?", "url": "https://questionsmedicales.fr/mesh/D006750?mesh_terms=Language+Development+Disorders&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Systèmes hospitaliers de distribution", "description": "Comment prévenir les erreurs de distribution ?\nQuelles pratiques pour une distribution efficace ?\nComment impliquer le personnel dans la prévention ?\nQuels audits pour prévenir les problèmes ?\nComment sensibiliser aux risques de distribution ?", "url": "https://questionsmedicales.fr/mesh/D006750?mesh_terms=Language+Development+Disorders&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Systèmes hospitaliers de distribution", "description": "Quelles solutions pour améliorer la distribution ?\nComment former le personnel sur la distribution ?\nQuels outils pour optimiser la distribution ?\nComment intégrer la technologie dans la distribution ?\nQuels protocoles pour la distribution sécurisée ?", "url": "https://questionsmedicales.fr/mesh/D006750?mesh_terms=Language+Development+Disorders&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Systèmes hospitaliers de distribution", "description": "Quelles complications d'une mauvaise distribution ?\nComment les erreurs de distribution affectent-elles les patients ?\nQuels coûts associés aux erreurs de distribution ?\nComment minimiser les complications ?\nQuels impacts sur la réputation de l'hôpital ?", "url": "https://questionsmedicales.fr/mesh/D006750?mesh_terms=Language+Development+Disorders&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Systèmes hospitaliers de distribution", "description": "Quels facteurs augmentent les erreurs de distribution ?\nComment le volume de patients influence-t-il la distribution ?\nQuels rôles jouent la technologie dans les risques ?\nComment l'environnement hospitalier affecte-t-il la distribution ?\nQuels impacts des changements de personnel sur la distribution ?", "url": "https://questionsmedicales.fr/mesh/D006750?mesh_terms=Language+Development+Disorders&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment évaluer l'efficacité d'un système de distribution ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'efficacité se mesure par la rapidité, la précision et la satisfaction des utilisateurs." } }, { "@type": "Question", "name": "Quels indicateurs surveiller dans un système de distribution ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Surveillez les délais de livraison, les erreurs de distribution et les coûts associés." } }, { "@type": "Question", "name": "Comment identifier les problèmes dans la distribution ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Utilisez des audits réguliers et des retours d'expérience des utilisateurs pour détecter les problèmes." } }, { "@type": "Question", "name": "Quels outils pour le diagnostic des systèmes de distribution ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des logiciels de gestion et des tableaux de bord analytiques aident à diagnostiquer les systèmes." } }, { "@type": "Question", "name": "Comment mesurer la satisfaction des utilisateurs ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des enquêtes et des interviews permettent d'évaluer la satisfaction des utilisateurs du système." } }, { "@type": "Question", "name": "Quels symptômes d'un système de distribution défaillant ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Retards fréquents, erreurs de commande et plaintes des utilisateurs sont des symptômes clés." } }, { "@type": "Question", "name": "Comment reconnaître une surcharge du système ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Des temps d'attente prolongés et une augmentation des erreurs signalées indiquent une surcharge." } }, { "@type": "Question", "name": "Quels impacts sur les patients d'un mauvais système ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des retards dans la distribution peuvent entraîner des complications médicales pour les patients." } }, { "@type": "Question", "name": "Quels signes d'inefficacité dans la distribution ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des coûts élevés et des niveaux de stock inappropriés signalent une inefficacité dans le système." } }, { "@type": "Question", "name": "Comment les erreurs de distribution se manifestent-elles ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Elles se manifestent par des médicaments incorrects ou des doses inappropriées livrées aux patients." } }, { "@type": "Question", "name": "Comment prévenir les erreurs de distribution ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Des vérifications en double et des systèmes de double contrôle aident à prévenir les erreurs." } }, { "@type": "Question", "name": "Quelles pratiques pour une distribution efficace ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Adopter des pratiques standardisées et des formations régulières pour le personnel est crucial." } }, { "@type": "Question", "name": "Comment impliquer le personnel dans la prévention ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Encourager le retour d'expérience et la communication ouverte aide à impliquer le personnel." } }, { "@type": "Question", "name": "Quels audits pour prévenir les problèmes ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Des audits réguliers et des évaluations de performance permettent d'identifier les problèmes potentiels." } }, { "@type": "Question", "name": "Comment sensibiliser aux risques de distribution ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Des campagnes de sensibilisation et des formations ciblées aident à informer sur les risques." } }, { "@type": "Question", "name": "Quelles solutions pour améliorer la distribution ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "L'implémentation de technologies comme la RFID et des logiciels de gestion peut aider." } }, { "@type": "Question", "name": "Comment former le personnel sur la distribution ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des sessions de formation régulières et des manuels d'utilisation sont essentiels pour le personnel." } }, { "@type": "Question", "name": "Quels outils pour optimiser la distribution ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des systèmes de gestion des stocks et des logiciels de planification améliorent l'optimisation." } }, { "@type": "Question", "name": "Comment intégrer la technologie dans la distribution ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "L'intégration de systèmes automatisés et de suivi numérique améliore l'efficacité de la distribution." } }, { "@type": "Question", "name": "Quels protocoles pour la distribution sécurisée ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Établir des protocoles clairs et des vérifications régulières garantit une distribution sécurisée." } }, { "@type": "Question", "name": "Quelles complications d'une mauvaise distribution ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications médicales, des infections et des hospitalisations prolongées peuvent survenir." } }, { "@type": "Question", "name": "Comment les erreurs de distribution affectent-elles les patients ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent entraîner des effets indésirables graves et des retards dans le traitement." } }, { "@type": "Question", "name": "Quels coûts associés aux erreurs de distribution ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les erreurs entraînent des coûts supplémentaires en soins, en traitements et en réhospitalisations." } }, { "@type": "Question", "name": "Comment minimiser les complications ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Mettre en place des protocoles stricts et des vérifications peut réduire les complications." } }, { "@type": "Question", "name": "Quels impacts sur la réputation de l'hôpital ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Des erreurs fréquentes peuvent nuire à la réputation de l'hôpital et à la confiance des patients." } }, { "@type": "Question", "name": "Quels facteurs augmentent les erreurs de distribution ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Un personnel insuffisamment formé et des systèmes obsolètes augmentent les erreurs." } }, { "@type": "Question", "name": "Comment le volume de patients influence-t-il la distribution ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Un volume élevé de patients peut surcharger le système et augmenter les risques d'erreurs." } }, { "@type": "Question", "name": "Quels rôles jouent la technologie dans les risques ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Une technologie mal intégrée peut créer des failles et des erreurs dans la distribution." } }, { "@type": "Question", "name": "Comment l'environnement hospitalier affecte-t-il la distribution ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Un environnement chaotique et mal organisé peut contribuer à des erreurs de distribution." } }, { "@type": "Question", "name": "Quels impacts des changements de personnel sur la distribution ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Des changements fréquents de personnel peuvent entraîner des incohérences et des erreurs." } } ] } ] }

Sources (10000 au total)

Plasma neuropeptide levels in patients with schizophrenia, bipolar disorder, or major depressive disorder and healthy controls: A multiplex immunoassay study.

We aimed to compare neuropeptide levels between patients with major psychiatric disorders and healthy controls and examine their association with symptoms and cognitive function.... The participants were 149 patients with schizophrenia, 115 patients with bipolar disorder (BD), 186 unremitted patients with major depressive disorder (MDD), and 350 healthy controls. Psychiatric (sch... The verification assay revealed that CSF α-MSH, β-endorphin, neurotensin, oxytocin, and substance P levels were too low to be reliably measured, while plasma α-MSH, β-endorphin, neurotensin, oxytocin,... Our data suggest that plasma neuropeptide levels do not elucidate the involvement of neuropeptides in the pathology of schizophrenia, BD, or MDD....

Can developmental trauma disorder be distinguished from posttraumatic stress disorder? A symptom-level person-centred empirical approach.

Developmental Trauma Disorder (DTD) is a proposed childhood psychiatric diagnosis for psychopathological and developmental sequela of victimization and attachment trauma extending beyond posttraumatic... To determine whether a sub-group of trauma-impacted children is characterized by symptoms of DTD that extend beyond, or co-occur with, the symptoms of PTSD.... Person-centred Latent Class Analyses (LCA) were done with data from 507 children (ages 7-18 years, (... A four class solution was optimal (LMR = 398.264,... Symptoms of DTD may occur with, or separately from, PTSD symptoms. Children with high DTD|+PTSD symptoms had extensive psychiatric comorbidity, while those with high DTD symptoms and minimal PTSD symp...

Substance Use, Substance Use Disorders, and Co-Occurring Psychiatric Disorders in Recently Incarcerated Men: A Comparison with the General Population.

The rates of alcohol and illegal drug use and the prevalence of alcohol and illegal drug use disorders (AUDs and DUDs) are high in prison populations, particularly in men entering jail. However, these... We based our research on two surveys, conducted in the same French region, which included a total of 630 men entering jail and 5,793 men recruited from the general population. We used the Mini-Interna... Compared to the general population sample, the prevalence of AUD (33.8% vs. 8.7%, p < 0.001) and DUD (at least one type of drug: 28.7% vs. 5.0%, p < 0.001; cannabis: 24.0% vs. 4.7%, p < 0.001; opioids... As in most countries, AUD and DUD are highly prevalent among men entering jail in France. Our results also suggest that incarceration constitutes an independent vulnerability factor for a dual disorde...

Functional urination or defecation disorders may be warning signs of attention-deficit/hyperactivity disorder among children in rural China.

This study was designed to investigate the prevalence of attention-deficit/hyperactivity disorder (ADHD) and its association with functional urination and defecation disorders among children in rural ... A cross-sectional study was conducted with children aged 6-18 in rural schools in southwest China using a survey questionnaire. The Swanson, Nolan, and Pelham Questionnaire-IV (SNAP-IV) was used to me... A total of 17,279 participants were included in the analyses. The prevalence of ADHD was 2 % mainly among boys before age 12, after which it showed a decreasing trend with age, resulting in a concomit... ADHD was associated with LUTS and FDDs, which highlights that functional urination and/or defecation disorders could serve as warning signs for ADHD that should trigger screening, especially in relati...

Treatment of Attention-Deficit/Hyperactivity Disorder with Medication in Children with Autism Spectrum Disorder With and Without Intellectual Disability: A DBPNet Study.

Children with autism spectrum disorder (ASD) and intellectual disability (ID)/global delay (GD) frequently have symptoms of attention-deficit/hyperactivity disorder (ADHD). We describe the practice pa...

Substance use disorder risk assessment: positive emotional experiences with first time use and substance use disorder risk.

Substance Use Disorder (SUD) screening tools used in current practice are designed to identify SUD once patients have begun regular dangerous drug use. While these screening tools are valuable, preven... The study involved a self-administered survey using a cross-sectional design and was carried out over one-month in the spring of 2021. Those patients who presented to the MAT clinic (SUD group) were s... The MAT group felt more positive feelings with first usage of alcohol and opioids compared to the comparison group (p<.001). With first usage of opioids specifically, MAT (0.13 ± 0.04) and comparison ... This retrospective cross-sectional report shows the first affective responses to substances may predict risk for future SUD and could be a prevention screening tool. Asking patients about positive fee...